Sain Medicaments Private Limited, a active private limited company, was established on 30 June 1983 in Ap, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1983PTC004015. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 23 professional, Its leadership includes Sumit Agarwal (Director), Girish Gupta (Managing Director), Kumud Agarwal (Director). Past directors included Radheshyam Kanodia Hazarilal, Sunil Radheshyam Gupta. It holds ₹10.90 Cr open charges and ₹0.85 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 10 H V S Building Complexhyderabad Ap, Ap, Telangana, 500095.
U24230TG1983PTC004015
004015
30 June 1983
₹1.00 Cr
₹1.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sain Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Agarwal | Director | 01 Sep 2009 | Current |
| Girish Gupta | Managing Director | 30 Jun 1983 | Current |
| Kumud Agarwal | Director | 01 Jan 1985 | Current |
| Manmeet Agarwal | Director | 01 Jul 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Dec 2020 | Past |
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sain Medicaments Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 1.16% decrease. The company also saw a slight decrease in profitability, with a 2.95% decrease in profit. The company's net worth moved up by a moderate rise of 1.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Sain Medicaments had a promoter holding of 87.61% and a public holding of 12.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹109,000,000.00
₹849,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2023 | Hdfc Bank Limited | ₹3.40 M | Open |
| 19 May 2018 | Hdfc Bank Limited | ₹10.56 Cr | Open |
| 17 Jun 1996 | Syndicate Bank | ₹0.25 M | Satisfied |
| 09 Mar 1995 | Syndicate Bank | ₹0.60 M | Satisfied |
Explore comprehensive loan charge details -
Sain Medicaments has a workforce of 23 employees as of Nov 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sain Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sain Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 10.56 Cr registered on 19 May 2018 with Charge ID 100182644 was modified on 28 Oct 2024. was completed.
Sain Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Sain Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.34 Cr with Charge ID 100786754 was registered on 08 Sep 2023. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 10.56 Cr with Charge ID 100182644 was registered on 19 May 2018. was documented.
Progress on Manmeet Agarwal was appointed as a Director was appointed as a Director on 01 Jul 2011 & has been associated with this company since 14 years 5 months . was documented.
The CIN of Sain Medicaments Private Limited is U24230TG1983PTC004015.
Sain Medicaments Private Limited is headquartered at 10 H V S Building Complexhyderabad Ap, Ap, Telangana, 500095.
Sain Medicaments Private Limited was incorporated on 30 June 1983.
The current directors of Sain Medicaments Private Limited are
The primary industry of Sain Medicaments Private Limited is Manufacturing.
Sain Medicaments Private Limited is unlisted.
The authorized capital of Sain Medicaments Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Sain Medicaments Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX